← Open Payments lookup

OLAIDE AKINYINKA: Open Payments

NPI 1932637097 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,015 in 38 payments from 10 companies in 2025. Trend: 2023 $1,344 · 2024 $1,309 · 2025 $1,015

Food & beverage: $1,015
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$179
ABBVIE INC.13$174
Alkermes, Inc.5$170
Axsome Therapeutics, Inc.4$147
Otsuka America Pharmaceutical, Inc.4$92
Teva Pharmaceuticals USA, Inc.1$84
Neurocrine BioSciences, Inc.2$69
Takeda Pharmaceuticals U.S.A., Inc.3$53
Bausch Health US, LLC2$32
Supernus Pharmaceuticals, Inc.1$15

Products named: CAPLYTA, VRAYLAR, Auvelity, LYBALVI, ARISTADA, AUSTEDO XR, REXULTI, INGREZZA.

Industry payments across TX — which companies pay providers there.